Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis
- PMID: 15813816
- DOI: 10.1111/j.1398-9995.2005.00774.x
Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis
Abstract
Background: Expression of CCR4 ligands, such as thymus and activation-regulated chemokine (TARC) and macrophage-derived chemokine (MDC), leads to preferential influx of T-helper (Th) 2-type lymphocytes to the lesional skin in atopic dermatitis (AD). Eotaxin, like the CCR3 ligand, is an important contributor of eosinophils recruitment in the course of AD. These chemokines are assumed to play an important role in the pathomechanism of AD.
Methods: In this study, the serum concentration of TARC, MDC, eotaxin and total immunoglobulin E (IgE) in AD patients and healthy people were compared. Correlation between the studied indices and activity of AD was established. Severity of AD was assessed according to the SCORAD score. The study comprised 44 healthy people and 43 patients with AD. The serum concentrations of TARC, MDC, eotaxin and IgE were measured with the use of enzyme-linked immunosorbent assay kits.
Results: The serum levels of TARC, MDC, eotaxin and IgE appeared to be significantly higher in patients with AD than in healthy people. A strong positive correlation was revealed between the levels of TARC, MDC, total IgE in serum of patients with AD and SCORAD. In contrast, no significant relationship was found for the serum eotaxin concentration and TARC, MDC, IgE or disease severity.
Conclusion: Our findings indicate that TARC and MDC are actively involved in the pathogenesis of AD and their expression, opposite to that of eotaxin, is strongly associated with clinical picture of atopic dermatitis.
Similar articles
-
Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.J Allergy Clin Immunol. 2001 Mar;107(3):535-41. doi: 10.1067/mai.2001.113237. J Allergy Clin Immunol. 2001. PMID: 11240957
-
Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.J Dermatol Sci. 2004 May;34(3):201-8. doi: 10.1016/j.jdermsci.2004.01.001. J Dermatol Sci. 2004. PMID: 15113590
-
Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.Br J Dermatol. 2006 Jun;154(6):1112-7. doi: 10.1111/j.1365-2133.2006.07201.x. Br J Dermatol. 2006. PMID: 16704642
-
Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases.J Dermatol Sci. 2006 Aug;43(2):75-84. doi: 10.1016/j.jdermsci.2006.06.002. Epub 2006 Jul 21. J Dermatol Sci. 2006. PMID: 16859899 Review.
-
Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis.J Dermatol. 2014 Mar;41(3):221-9. doi: 10.1111/1346-8138.12440. J Dermatol. 2014. PMID: 24628072 Review.
Cited by
-
Cinnamomum camphora Leaves Alleviate Allergic Skin Inflammatory Responses In Vitro and In Vivo.Toxicol Res. 2019 Jul;35(3):279-285. doi: 10.5487/TR.2019.35.3.279. Epub 2019 Jul 15. Toxicol Res. 2019. PMID: 31341557 Free PMC article.
-
Di-(2-ethylhexyl) phthalate enhances atopic dermatitis-like skin lesions in mice.Environ Health Perspect. 2006 Aug;114(8):1266-9. doi: 10.1289/ehp.8985. Environ Health Perspect. 2006. PMID: 16882537 Free PMC article.
-
A transcription factor PU.1 is critical for Ccl22 gene expression in dendritic cells and macrophages.Sci Rep. 2019 Feb 4;9(1):1161. doi: 10.1038/s41598-018-37894-9. Sci Rep. 2019. PMID: 30718772 Free PMC article.
-
Targeting key proximal drivers of type 2 inflammation in disease.Nat Rev Drug Discov. 2016 Jan;15(1):35-50. doi: 10.1038/nrd4624. Epub 2015 Oct 16. Nat Rev Drug Discov. 2016. PMID: 26471366 Review.
-
Senecio scandens Buch.-Ham. polysaccharides exert anti-atopic dermatitis effects by modulating gut microbiota and the MAPK/NF-κB pathway.Front Pharmacol. 2025 Mar 26;16:1573135. doi: 10.3389/fphar.2025.1573135. eCollection 2025. Front Pharmacol. 2025. PMID: 40206087 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources